Oriental Carbon and Chemicals (OCCL) Q4 16/17 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 16/17 earnings summary
2 Nov, 2026Executive summary
FY2016-17 standalone net revenue rose to Rs 29,745.16 lakh from Rs 27,471.72 lakh; PAT was Rs 5,343.23 lakh versus Rs 5,298.73 lakh.
Insoluble Sulphur sales grew about 9%, supported by Mundra’s first expansion phase, commissioned in December 2016.
Financial highlights
Standalone revenue from operations was Rs 29,745.16 lakh, up from Rs 27,471.72 lakh; total revenue was Rs 30,405.12 lakh versus Rs 28,040.36 lakh.
EBITDA before finance costs, depreciation and tax was Rs 9,387.29 lakh versus Rs 8,676.12 lakh; PBT was Rs 7,358.33 lakh versus Rs 6,476.32 lakh.
PAT was Rs 5,343.23 lakh versus Rs 5,298.73 lakh; EPS was Rs 51.90 versus Rs 51.46.
FY2016-17 PAT included a deferred tax credit of Rs 791.72 lakh, attributed to the new Mundra capacity.
Outlook and guidance
Global Insoluble Sulphur demand growth forecast at 3–4% annually; domestic demand expected to grow at double-digit rates.
Phase II of Mundra Insoluble Sulphur expansion was under way, with commissioning expected in Q2 FY2018-19.
China and the US were identified as growth markets; new tyre-customer approvals and Ultra High Performance Tyres were expected to support demand.
Latest events from Oriental Carbon and Chemicals
- Profitable growth and a ₹216 crore expansion plan advance the next capacity phase.OCCL
Q4 18/19 - COVID-19 hit FY20 results; FY21 outlook signaled lower sales and delayed expansion.OCCL
Q4 19/20 - Higher FY18 profit and expanding Insoluble Sulphur capacity underpin the growth outlook.OCCL
Q4 17/18 - Higher margins lifted PAT despite weaker sales; Mundra expansion was due in April 2017.OCCL
Q4 15/16 - FY15 profit advanced as Insoluble Sulphur demand and capacity utilization strengthened.OCCL
Q4 14/15 - FY14 growth was led by Insoluble Sulphur, with expansion prospects shadowed by SEZ uncertainty.OCCL
Q4 13/14 - Sales rose, but lower tyre demand and higher costs cut earnings as Mundra Phase II ramped up.OCCL
Q4 12/13 - FY11 profit rose as capacity expansion targeted strong Insoluble Sulphur demand.OCCL
Q4 10/11 - Revenue grew 37%, while Mundra expansion lifted Insoluble Sulphur capacity amid higher costs and market risks.OCCL
Q4 11/12